Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
Hélène Chifflot(Hôpital d'Hautepierre), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Bruno Fautrel, Christelle Sordet, Emmanuel Chatelus(Laboratoire National de Référence)
Cited by 456
Related Papers
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
|The Lancet Rheumatology|2021|292
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207